The Globe and Mail reports in its Thursday, April 11, edition that Scotia Capital analyst Konark Gupta has reaffirmed his "sector outperform" recommendation for Heroux-Devtek. The Globe's David Leeder writes in the Eye On Equities column that Mr. Gupta elevated his share target to $22.50 from $21. Analysts on average target the shares at $23.90. Mr. Gupta says in a note: "Bombardier offers the best downside protection, but Q1 may not impress due to FCF seasonality and delivery mix. We see CAE as the only beat candidate, but the stock is likely to react to guidance and defence segment narrative. Heroux-Devtek may not surprise much." The Globe reported on May 20 and Jan. 23 that Mr. Gupta had an unchanged "sector outperform" call on Heroux-Devtek, which was then worth $14.25 and $15.18. The Globe reported on Aug. 10 and Feb. 9 that Desjardins Securities analyst Benoit Poirier rated Heroux-Devtek "buy" when it was worth $15.70 and $18.05.